Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Mimecast spurns Proofpoint's higher take-private bid over antitrust concerns

Published 13/01/2022, 20:14
© Reuters.

By Krystal Hu

(Reuters) - Mimecast Ltd, the email security provider that announced a deal to go private last month, has rejected a higher offer from Thoma Bravo-backed Proofpoint due to antitrust risks, according to regulatory filings and sources familiar with the situation.

Proofpoint offered $92.50 cash per share on Dec. 31, weeks after private equity firm Permira signed a $5.8 billion deal to buy Mimecast with a 30-day go-shop period during which Mimecast can talk with other parties, said the people, who requested anonymity to discuss private matters.

While the offer is 16% higher than Permira's bid of $80 per share, Mimecast rejected Proofpoint's request to conduct due diligence, citing antitrust risks of merging two major email security vendors, the people said.

Mimecast's special committee reviewed the offer with legal counsels and concluded a combination of two competitors could control over 50% of the email security market. They believed such deal would likely result in a lengthy review by antitrust regulators, and few remedies such as divestitures are available, the people said.

After several discussions, Mimecraft did not feel its concerns were adequately addressed by Proofpoint, which had indicated it could raise its offer further pending due diligence.

"After considering all the alternatives available to Mimecast, the Board of Directors determined that the Permira transaction is in the best interests of shareholders and the Company," a spokesperson for Mimecast said in a statement.

"It maximizes value, delivering a significant cash premium with a clear path to close."

Proofpoint declined to comment. Thoma Bravo, a private equity firm which took Proofpoint private in a $12.3 billion deal last April, did not respond to a request for comment.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Permira deal is expected to close in the first half of 2022, subject to shareholder approval.

Mimecast shares rose 1.43% to $80.32.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.